McGill University Health Centere (MUHC)-Glen Site

Montreal, Quebec H4A 3J1

0 studies enrolling now · 1 studies all time

What they study most

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Cancer

Studies at this site

• REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 — Stopped early